AGP Picks
View all

Raadsr.ai launches AI mental health screening platform with personalized reports

6 hours ago
By AI, Created 05:01 UTC, Aug 19, 2026, AGP -

Tensority, LLC launched Raadsr.ai on August 19, 2026 as a mental health assessment platform that pairs standardized screening tools with AI-generated report analysis. The service is live now, starts with a free RAADS-R autism screening, and aims to help users understand response patterns before seeing a professional.

Why it matters: - Raadsr.ai tries to move mental health screening beyond a single total score and toward a fuller view of response patterns. - The platform could help people use standardized assessments more effectively before speaking with a clinician. - The launch comes as more than one billion people worldwide live with mental health conditions, while access to professional care remains limited.

What happened: - Tensority, LLC launched Raadsr.ai on August 19, 2026 in Newark, Delaware. - Raadsr.ai is a mental health assessment and reporting platform for individuals. - The platform combines standardized self-assessments, deterministic scoring and personalized AI analysis. - Raadsr.ai offers more than 30 screening instruments across 11 categories. - The supported categories include autism spectrum, ADHD, anxiety, depression, OCD, addiction, personality and trauma. - The flagship entry point is a free 80-item RAADS-R adult autism assessment. - After an eligible assessment, users receive rule-based scores and then a privately deployed AI generates a structured report.

The details: - Raadsr.ai uses server-verified, rule-based scoring for every supported assessment. - The score itself is not generated or altered by AI. - A privately deployed large language model reviews submitted answers and scoring patterns. - The report includes domain-level analysis, item-level references, response-pattern analysis and a checklist for discussion with a professional. - The assessment library includes standardized instruments that originate in peer-reviewed research. - The RAADS-R was evaluated in a 779-participant, multi-center international study published in the Journal of Autism and Developmental Disorders. - NICE guidance CG142 lists the RAADS-R as one formal tool that may be considered within a broader adult autism assessment. - The platform includes a multi-person workspace. - The $88 multi-person pack lets an account holder invite another consenting adult through a private, one-time link. - The workspace keeps consent records, assessment history, report status and follow-up notes in one place. - The flagship RAADS-R assessment, total score and four domain scores are free. - AI-generated detailed report packs start at $19 as a one-time purchase. - Raadsr.ai does not use a subscription model or automatic renewal. - Additional assessments across all 11 categories are available through report packs. - The platform is available now at raadsr.ai.

Between the lines: - The product is aimed at users who want more context from screening results before booking care. - The emphasis on deterministic scoring is meant to separate the score from the AI interpretation layer. - The multi-person workspace suggests the platform is also targeting shared or supported screening use cases.

What's next: - Users can start with the free RAADS-R screening and then choose paid report packs if they want deeper analysis. - Raadsr.ai is likely to expand usage as more people test the broader assessment library across the 11 categories. - The company positions the reports as a prep step for conversations with qualified professionals.

The bottom line: - Raadsr.ai is betting that standardized screening plus AI interpretation will make mental health assessments easier to understand and more actionable.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.